# Labcorp Completes Millennium Health Deal as Quarterly Revenue Gains 6.9% By John Kim Canonical URL: https://www.tokenpost.com/news/business/50441 Published: 2026-11-07T00:14:33.000Z Updated: 2026-11-07T00:14:33.000Z Section: Business > Third-quarter adjusted earnings per share rose 14.5%. Labcorp set 2026 revenue growth guidance at 5.9% to 6.7%. Labcorp completed its acquisition of Millennium Health on Nov. 4, after a quarter in which revenue climbed 6.9% and adjusted earnings per share rose 14.5%. Revenue for the quarter ended Sept. 30 reached $3.81 billion, compared with $3.56 billion a year earlier. Adjusted earnings per share rose to $4.78 from $4.18. Labcorp set its 2026 revenue growth outlook at 5.9% to 6.7% and its adjusted earnings per share guidance at $18.30 to $18.70. The outlook is higher than the company’s [July outlook](), which called for revenue growth of 5.4% to 6.3% and adjusted earnings per share of $18.10 to $18.55. Labcorp also bought MLM Medical Labs. After Sept. 30, it signed deals involving Millennium Health, Myriad Genetics’ prenatal testing business and BioReference Health assets. The Nov. 4 completion finalized the Millennium deal. “Labcorp delivered another strong quarter with 7% revenue growth, continued margin expansion and 14.5% adjusted EPS growth, leading to a raise in our full-year guidance,” said Adam Schechter, chairman and CEO of Labcorp. ## Links in this article - [July outlook](https://www.tokenpost.com/news/business/31948)